Ignite Creation Date:
2025-12-24 @ 4:11 PM
Ignite Modification Date:
2026-03-05 @ 12:06 AM
Study NCT ID:
NCT03221166
Status:
TERMINATED
Last Update Posted:
2020-09-04
First Post:
2017-07-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Thalidomide Versus Infliximab in New Onset Crohn's Disease With Poor Prognostic Factors
Sponsor:
IRCCS Burlo Garofolo
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
NET-2013-02355002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None